The Patent Finder

Immerge Biotherapeutics, Inc.

Also on record
Records under this name other than patents Immerge Biotherapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Immerge Biotherapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,547,522Method to enrich for α(1,3)-galactosyltransferase null pig cells
Term ended
Term ended Feb 10, 2024 · USPTO record
Term endedTerm ended Feb 10, 2024USPTO record
US 7,547,816ALPHA(1,3)-GALACTOSYLTRANSFERASE Knockout Swine, Tissues and Organs
Term ended
Term ended Sep 11, 2023 · High confidence
Term endedTerm ended Sep 11, 2023High confidence
US 6,461,811Gamma-herpes virus DNA and methods of use
Term ended
Term ended Jul 7, 2020 · USPTO record
Term endedTerm ended Jul 7, 2020USPTO record
US 6,942,863Gamma herpesvirus DNA and methods of use
Lapsed on the fee record
Ended Sep 13, 2013 · USPTO record
Lapsed on the fee recordEnded Sep 13, 2013USPTO record
US 6,867,347Swine defective for transmission of porcine endogenous retrovirus and uses thereof
Lapsed on the fee record
Ended Mar 15, 2013 · USPTO record
Lapsed on the fee recordEnded Mar 15, 2013USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited